Your session is about to expire
← Back to Search
Study Summary
This trial will observe patients who are already taking regorafenib in order to collect safety data and assess tolerability of the drug.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What other purposes has this medication been shown to help with?
"This treatment is often used for the treatment of liver cancer. It can also be prescribed to treat various other conditions, such as those that have previously been treated with anti-VEGF therapy or those that are receiving amino acid supplementation."
Does this clinical trial represent a new development in treatment?
"At present, there are 109 ongoing trials for this medication in 33 countries and 1327 cities. The first trial began in 2007 and was sponsored by Baxter Healthcare Corporation. That initial study completed its Phase 4 drug approval stage with 4640 patients enrolled. Since then, an additional 119 studies have concluded."
Are there any risks associated with this treatment that patients should be made aware of?
"The safety of this intervention was estimated to be a 2. This is due to the fact that, while Phase 2 trials offer some preliminary evidence regarding safety, there is no data at this time to support efficacy claims."
Are there still places available in this clinical trial for new participants?
"Unfortunately, this trial is no longer looking for patients. However, when it was active, the study was originally posted on April 2nd, 2019 and last updated on November 9th, 2023. There are currently two trials actively recruiting participants with solid cancers and 109 other trials for this treatment that are still seeking patients."
How many people fit the necessary qualifications to join this experiment?
"Unfortunately, this particular trial is no longer looking for patients. The listing was created on April 2nd, 2019 but the most recent update was on November 9th, 2020. Out of the 109 other trials exploring this treatment, only 2 are actively recruiting right now."
Have there been other similar medical studies in the past that used this treatment?
"At the moment, 109 clinical trials are underway to study this intervention. Out of those, 11 are in Phase 3. The vast majority of these studies are taking place in Tampa, Florida; however, 8144 different locations worldwide are running trials for this treatment."
Share this study with friends
Copy Link
Messenger